Therapeutic hyperthermia

Perfusion

Volumn 11, Issue 6, 1996, Pages 425-435

  Alpard, Scott K ^a   Vertrees, Roger A ^a   Tao, Weike ^a   Deyo, Donald J ^a   Brunston Jr , Robert L ^a   Zwischenberger, Joseph B ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER THERAPY; CORE TEMPERATURE; HUMAN; HYPERTHERMIC THERAPY; METHODOLOGY; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SALVAGE THERAPY; TUMOR BLOOD FLOW; VASODILATATION; VIRUS INFECTION;

EID: 0030458573     PISSN: 02676591     EISSN: None     Source Type: Journal    
DOI: 10.1177/026765919601100602     Document Type: Review

References (115)

1. Adams F. The genuine works of Hippocrates. New York: William Wood & Co, 1886: 273.
2. Gabriele P, Orecchia R, Ragona R, Tseroni V, Sannazzari GL. Hyperthermia alone in the treatment of recurrences of malignant tumors. Experience with 60 lesions. Cancer 1990; 66: 2191-95.
3. Robins HI, Hugander A, Cohen JD. Whole body hyperthermia in the treatment of neoplastic disease. Radiol Clin North Am 1989; 27: 603-10.
4. Storm FK. Clinical hyperthermia and chemotherapy [Review]. Radiol Clin North Am 1989; 27: 621-27.
5. Neese RM, Williams GC. Why we get sick. New York: Time Life, 1994: 26.
6. Snell ES, Atkins E. The mechanisms of fever. In: Bittar EE, Bittar N eds. The biological basis of medicine. New York: Academic Press, 1968: 397-419.
7. Li GC. Thermal biology and physiology in clinical hyperthermia: current status and future needs. Cancer Res 1984; 44: 4886s-93s.
8. Kerr JFR, Winterford CM, Harmon BV. Apoptosis. Its significance in cancer and cancer therapy. Cancer 1994; 73: 2013-26.
9. Cavaliere R, Ciocatto EC, Giovanella BC et al. Selective heat sensitivity of cancer cells. Biochemical and clinical studies. Cancer 1967; 20: 1351-81.
10. Shibata HR, MacDlean LD. Blood flow to tumors. Prog Clin Cancer 1966; 2: 33-47.
11. Sapareto SA, Hopwood LE, Dewey WC, Raju MR, Gray JW. Effects of hyperthermia on survival and progression of Chinese hamster ovary cells. Cancer Res 1978; 38: 393-400.
12. Bicher HI, Hetzel FW, Sandhu TS et al. Effects of hyperthermia on normal and tumor microenvironment. Radiology 1980; 137: 523-30.
13. Reinhold HS, van den Berg AP. Effects of hyperthermia in blood flow and metabolism. In: Field SB, Hand JW eds. An introduction to the practical aspects of clinical hyperthermia. London: Taylor & Francis, 1990: 77-107.
14. Song CW. Effects of local hyperthermia on blood flow and microenvironment: a review. Cancer Res 1984; 44(Suppl.): 4721S-30S.
15. Vaupel P, Müller-Klieser W, Otte J, Manz R, Kallinowski F. Blood flow, tissue oxygenation, and pH-distribution in malignant tumors upon localized hyperthermia. Basic pathophysiological aspects and the role of various thermal doses. Strahlentherapie 1983; 159: 73-81.
16. Freeman ML, Dewey WC, Hopwood LE. Effect of pH on hyperthermic cell survival. J Natl Cancer Inst 1977; 58: 1837-39.
17. Fellenz MP, Gerweck LE. Influence of extracellular pH on intracellular pH and cell energy status: relationship to hyperthermic sensitivity. Radiat Res 1988; 116: 305-12.
18. Hofer KG, Mivechi NF. Tumor cell sensitivity to hyperthermia as a function of extracellular pH and intracellular pH. J Natl Cancer Inst 1980; 65: 621-25.
19. Lyons JC, Kim GE, Song CW. Modification of intracellular pH and thermosensitivity. Radiat Res 1992; 129: 79-87.
20. Overgaard J. Influence of extracellular pH on the viability and morphology of tumor cells exposed to hyperthermia. J Natl Cancer Inst 1976; 56: 1243-50.
21. Gerweck LE. Modification of cell lethality at elevated temperatures: the pH effect. Radiat Res 1977; 70: 224-35.
22. Kruger W, Mayer WK, Schaefer C et al. Acute changes of systemic parameters in tumor-bearing rats, and of tumor glucose, lactate, and ATP levels upon local hyperthermia and/or hyperglycemia. J Cancer Res Clin Oncol 1991; 117: 409-15.
23. Van Der Zee J, Broekmeyer-Reurink MP, van den Berg AP et al. Temperature distribution and pH changes during hyperthermic regional isolation perfusion. Eur J Cancer Clin Oncol 1989; 25: 1157-63.
24. Reinhold HS, Wike-Hooley JL, van den Berg AP. Environmental factors, blood flow and microcirculation. In: Overgaard J ed. Hyperthermia oncology, Vol. II. London: Taylor & Francis, 1985: 41-52.
25. Haveman J. Influence of pH and thermotolerance on the enhancement of x-ray induced inactivation of cultured mammalian cells by hyperthermia. Int J Radiat Biol 1983; 63: 281-89.
26. Holahan EV, Highfield DP, Holahan PK, Dewey WC. Hyperthermic killing and hyperthermic radiosensitization in Chinese hamster ovary cells: Effects of pH and thermotolerance. Radiat Res 1984; 97: 108-31.
27. Engin K, Leeper DB, Thistlethwaite AJ, Tupchong L, McFarlane DP, McFarlane JD. Tumor extracellular pH as a prognostic factor in thermoradiotherapy. Int J Radiat Oncol Biol Phys 1994; 29: 125-32.
28. Overgaard J, Nielsen OS. The role of tissue environmental factors on the kinetics and morphology of tumor cells exposed to hyperthermia. In: Jain RK, Gullino PM eds. Thermal characteristics of tumors: applications in detection and treatment. New York: New York Academy of Sciences, 1980: 254-78.
29. Wike-Hooley JL, Haveman J, Reinhold HS. The relevance of tumour pH to the treatment of malignant diseases. Radiother Oncol 1984; 2: 343-66.
30. Vaupel P, Frinak S, Müller-Klieser W, Bicher HI. Impact of localized hyperthermia on the cellular microenvironment in solid tumors. Natl Cancer Inst Monogr 1982; 61: 207-209.
31. Song CW, Kang MS, Rhee JG, Levitt SH. The effect of hyperthermia on vascular function, pH, and cell survival. Radiology 1980; 137: 795-803.
32. Vaupel P. Impact of localized microwave hyperthermia on the pH-distribution in malignant tumors. Strahlentherapie 1982; 158: 168-73.
33. Overgaard K, Overgaard J. Investigations on the possibility of a thermic tumour therapy. I. Short wave treatment of a transplanted isologous mouse mammary carcinoma. Eur J Cancer 1972; 8: 65-78.
34. Hahn GM, Shiu EC. Adaptation to low pH modifies thermal and thermochemical responses of mammalian cells. Int J Hyperthermia 1986; 2: 379-87.
35. Bass H, Moore JL. Lethality in mammalian cells due to hyperthermia under oxic and hypoxic conditions. Int J Radiat Biol 1978; 33: 57-67.
36. Gerwock LE, Nygaard TG, Burlett M. Response of cells to hyperthermia under acute and chronic hypoxic conditions. Cancer Res 1979; 39: 966-72.
37. Dyson JED, Simmons DM, Daniel J, McLaughlin JM, Quirke P, Bird CC. Kinetic and physical studies of cell death induced by chemotherapeutic agents or hyperthermia. Cell Tissue Kinet 1986; 19: 311-24.
38. Allan DJ, Harmon BV. The morphological categorization of cell death induced by mild hyperthermia and comparison with death induced by ionizing radiation and cytotoxic drugs. Scan Electron Microsc 1986; 3: 1121-33.
39. Allan DJ, Harmon BV, Kerr JFR. Cell death in spermatogenesis. In: Potten CS ed. Perspectives on mammalian cell death. Oxford: Oxford University Press, 1987: 229-58.
40. Harmon BV, Allen J, Gobe GC, Collins RJ, Kerr JFR, Allan DJ. Hyperthermic cell killing in murine tumours with particular reference to apoptosis. In: Sugahara T, Saito M eds. Hyperthermic oncology 1988, Vol. 1 (summary papers). London: Taylor & Francis, 1989: 129-30.
41. Walker NI, Harmon BV, Gobe GC, Kerr JFR. Patterns of cell death. Meth Achieve Exper Pathol (Basel) 1988; 13: 18-54.
42. Cohen JJ, Duke RC. Glucocorticoid activation of a calcium-dependant endonuclease in thymocyte nuclei leads to cell death. J Immunol 1984; 132: 38-42.
43. Sellins KS, Cohen JJ. Hyperthermia induces apoptosis in thymocytes. Radiat Res 1991; 126: 88-95.
44. Harmon BV, Takano YS, Winterford CM, Gobe GC. The role of apoptosis in the response of cells and tumours to mild hyperthermia. Int J Radiat Blol 1991; 59: 489-501.
45. Harmon BV, Conder AM, Collins RJ et al. Cell death induced in a murine mastocytoma by 42°-47°C heating in vitro: evidence that the form of death changes from apoptosis to necrosis above a critical heat load. Int J Radiat Biol 1990; 58: 845-58.
46. Mosser DD, Martin LH. Induced thermotolerance to apoptosis in a human T lymphocyte cell line. J Cell Physiol 1992; 151: 561-70.
47. Nahas GG, Tannieres ML, Lennon JF. Direct measurement of leukocyte motility: effects of pH and temperature. Proc Soc Exp Biol Med 1971; 138: 350-52.
48. Moore TC, Nur K, Storm FK. Localized deep hypothermia increases the traffic of lymphocytes through peripheral lymph nodes of sheep in vivo. J Surg Onc 1987; 35: 75-81.
49. Chang C-C, Wu JM. Modulation of antiviral activity and 2′,5′-oligoadenylate synthetase gene expression by mild hyperthermia (39.5°C) in cultured human cells. J Biol Chem 1991; 266: 4605-612.
50. Laszlo A. Evidence for two states of thermotolerance in mammalian cells. Int J Hyperthermia 1988; 4: 513-26.
51. Kappel M, Kharazmi A, Nielson H, Gyhrs A, Pedersen BK. Modulation of the counts and functions of neutrophils and monocytes under in vivo hyperthermia conditions. Int J Hyperthermia 1994; 10: 165-73.
52. Brett DE, Schloerb PR. Intermittent hyperthermia on Walker 256 carcinoma. Arch Surg 1962; 85: 1004-1007.
53. Dickson JA, Ellis HA. Stimulation of tumour cell dissemination by raised temperature (42°C) in rats with transplanted Yoshida tumours. Nature 1974; 248: 354-58.
54. Hahn GM, Li GC. Thermotolerance, thermoresistance, and thermosensitization. In: Morimoto RI, Tissieres A, Georgopoulos C eds. Stress proteins in biology and medicine. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1990: 79-100.
55. Ben-Hur E, Riklis E. Enhancement of thermal killing by polyamines. Radiat Res 1979; 78: 321-28.
56. Landry J, Lamarche S, Chretien P. Heat shock proteins: a lead to the understanding of cell thermotolerance. In: Henle K ed. Thermotolerance: thermotolerance and thermophily, Vol. I. Boca Raton, FL: CRC Press, 1987: 145-73.
57. Landry J, Dernier D, Chretien P, Nicole LM, Tanguay RM, Marceau N. Synthesis and degradation of heat shock proteins during development and decay of thermotolerance. Cancer Res 1982; 42: 2457-61.
58. Li GC, Werb Z. Correlation between synthesis of heat-shock proteins and development of tolerance to heat and to adriamycin in Chinese hamster fibroblasts: heat shock and other inducers. In: Schlesinger M, Ashburner M, Tissieres A eds. Heat shock, from bacteria to man. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1982: 395-404.
59. Subjeck JR, Sciandra JJ, Johnson RJ. Heat shock proteins and thermotolerance; a comparison of induction kinetics. Dr J Radiol 1982; 55: 579-84.
60. Li GC, Mivechi NF, Weitzel G. Heat shock proteins, thermotolerance, and the relevance to clinical hyperthermia. Int J Hyperthermia 1995; 11: 459-88.
61. Johnston RN, Kucey BL. Competitive inhibition of hsp70 gene expression causes thermosensitivity. Science 1988; 242: 1551-54.
62. Riabowol KT, Mizzen LA, Welch WJ. Heat shock is lethal to fibroblasts microinjected with antibodies against hsp70. Science 1988; 242: 433-36.
63. Landry J, Chretien P, Lambert H, Hickey E, Weber LA. Heat shock resistance conferred by expression of the human hsp27 gene in rodent cells. J Cell Biol 1989; 109: 7-15.
64. Li GC, Li L, Liu YK, Mak JY, Chen L, Lee MWF. Thermal response of rat fibroblasts stably transfected with the human 70-kDa heat shock protein-encoding gene. Proc Natl Acad Sci USA 1991; 88: 1681-85.
65. Mizzen LA, Welch WJ. Characterization of the thermotolerant cell. I. Effects on protein synthesis activity and the regulation of heat-shock protein 70 expression. J Cell Biol 1988; 106: 1105-16.
66. Sciandra JJ, Subjeck JR. Heat shock proteins and protection of proliferation and translation in mammalian cells. Cancer Res 1984; 44: 5188-94.
67. Yost HJ, Lindquist S. RNA splicing is interrupted by heat shock and is rescued by heat shock protein synthesis. Cell 1986; 45: 185-93.
68. Collier NC, Schlesinger MJ. The dynamic state of heat shock proteins in chicken embryo fibroblasts. J Cell Biol 1986; 103: 1495-507.
69. Welch WJ, Mizzen LA. Characterization of the thermotolerant cell. II. Effects on the intracellular distribution of heat-shock protein 70, intermediate filaments, and small nuclear ribonucleoprotein complexes. J Cell Biol 1988; 106: 1117-30.
70. Frazier OH. The use of hyperthermia in the treatment of cancer. Proc Am Acad Cardiovasc Perfusion 1982; 3: 99-104.
71. Pettigrew RT, Gait JM, Ludgate CM, Smith AN. Clinical effects of whole-body hyperthermia in advanced malignancy. Br Med J 1974; 4: 679-82.
72. Santinami M, Belli F, Cascinelli N, Rovini D, Vaglini M. Seven years' experience with hyperthermic perfusions in extracorporeal circulation for melanoma of the extremities. J Surg Oncol 1989; 42: 201-208.
73. Cavaliere R, Mondavi B, Moricca G et al. Regional perfusion hyperthermia. In: Storm KF ed. Hyperthermia in cancer. Boston, MA: GK Hall Medical, 1983: 369-98.
74. Giovanella BC, Lohman WA, Heidelberger C. Effects of elevated temperatures and drugs on the viability of L1210 leukemia cells. Cancer Res 1970; 30: 1623-31.
75. Stehlin JS. Hyperthermic perfusion with chemotherapy for cancers of the extremities. Surg Gynecol Obstet 1969; 129: 305-308.
76. Otte J. Hyperthermia in cancer therapy. [Review]. Eur J Pediatr 1988; 147: 560-69.
77. Herman TS, Zukoski CF, Anderson RM et al. Whole-body hyperthermia and chemotherapy for treatment of patients with advanced, refractory malignancies. Cancer Treat Rep 1982; 66: 259-65.
78. Bull JM, Lees D, Schuette W et al. Whole body hyperthermia: a phase I trial of a potential adjuvant to chemotherapy. Ann Intern Med 1979; 90: 317-23.
79. Larkin JM, Edwards WS, Smith DE, Clark PJ. Systemic thermotherapy: description of a method and physiologic tolerance in clinical subjects. Cancer 1977; 40: 3155-59.
80. Robins HI, Sielaff KM, Storer B, Hawkins MJ, Borden EC. Phase I trial of human lymphoblastoid interferon with whole body hyperthermia in advanced cancer. Cancer Res 1989; 49: 1609-15.
81. Parks LC, Smith GV. Systemic hyperthermia by extracorporeal induction: techniques and results. In: Storm FK ed. Hyperthermia in cancer therapy. Boston, MA: GK Hall Medical, 1983: 407-46.
82. Gibbs FA. Thermal mapping for experimental cancer treatment with hyperthermia: description and use of a semiautomatic system. Int J Rad Oncol Biol Phys 1983; 9: 1057-63.
83. Vertrees RA, Sites JP, Tao W, Pencil SP, Althoff DP, Zwischenberger JB. Induction of whole body hyperthermia with venovenous perfusion. ASAIO J 1996; 42: 250-54.
84. Vertrees RA, Tao W, Deyo D et al. Effects of blood flow rates on heat distribution heterogeneity during perfusion-induced hyperthermia [Abstract]. ASAIO J 1996; 42: 63.
85. Parks LC, Frazier OH, Mountain CF. Paper read at the Fourth annual conference of the Denton A Cooley society, Houston, TX, June 1977.
86. Parks LC, Minaberry D, Smith DP, Neely WA. Treatment of far-advanced bronchogenic carcinoma by extracorporeally induced systemic hyperthermia. J Thorac Cardiovasc Surg 1979; 78: 883-92.
87. Wong GHW, McHugh T, Goeddel DV. HIV-infected cells are more susceptible than uninfected cells to killing by irradiation, heat, or tumor necrosis factor. Second international conference on dug research in immunology and infectious disease: acquired immunodeficiency syndrome (AIDS), November 1989.
88. Logan WD, Alonso K. Case report: total body hyperthermia in the treatment of Kaposi's sarcoma in an HIV positive patient. Med Oncol Tumor Pharmacother 1991; 8: 45-47.
89. Cross CE, Halliwell B, Borish ET et al. Oxygen radicals and human disease [Clinical conference]. Ann Intern Med 1987; 107: 526-45.
90. Jamieson D. Oxygen toxicity and reactive oxygen metabolites in mammals. Free Rad Biol Med 1989; 7: 87-108.
91. Cole A, Armour EP. Ultrastructural study of mitochondrial damage in CHO cells exposed to hyperthermia. Radiat Res 1988; 115: 421-35.
92. Salet C, Passarella S, Quagliariello E. Effects of selective radiation on mammalian mitochondria [Review]. Photochem Photobiol 1987; 45: 433-38.
93. Wong GHW, McHugh T, Weber R, Goeddel DV. Tumor necrosis factor alpha selectively sensitizes human immunodeficiency virus-infected cells to heat and radiation. Proc Natl Acad Sci USA 1991; 88: 4372-76.
94. Shaw GM, Hagn BH, Arya SK, Groopman JE, Gallo RC, Wong-Staal F. Molecular characterization of human T-cell leukemia (lymphotropic) virus type III in the acquired immune deficiency syndrome. Science 1984; 226: 1165-71.
95. Ralhan RJ, Johnson GS. Destabilization of cytoplasmic mouse mammary tumor RNA by heat shock: prevention by cycloheximide pretreatment. Biochem Biophys Res Commun 1986; 137: 1028-33.
96. Puaza CD, Galindo JE, Richman DO. Reinfection results in accumulation of unintegrated viral DNA in cytopathic and persistent human immunodeficient virus type I infection of CEM cells. J Exp Med 1990; 172: 1035-42.
97. Keshet E, Temin HM. Cell killing by spleen necrosis virus is correlated with a transient accumulation of spleen necrosis virus DNA. J Virol 1979; 31: 376-88.
98. Ash SR, Gingrich CH, Rainier JB, Carr DJ, Steinhart CR, Keeling GN. Safety of whole body hyperthermia (WBHT) with hemodiabsorption in treatment of AIDS [Abstract]. ASAIO 1995; 41: 85.
99. Steinhart CR, Ash SR, Gingrich C, Sapir D, Keeling GN, Yatvin MB. Effect of whole-body hyperthermia on AIDS patients with Kaposi's sarcoma: a pilot study. JAIDS Human Retrovir 1996; 11: 271-81.
100. Ash SR. Hemodiabsorption in treatment of acute hepatic failure and chronic cirrhosis with ascites. Artif Organs 1994; 18: 355-62.
101. Chunn GD, Kirkpatrick CL. Fatal result of artificial fever therapy: a case report. Milit Surg 1937; 81: 281-87.
102. Hartman FW, Major RC. Pathological changes resulting from accurately controlled artificial fever. Am J Clin Path 1935; 5: 392-410.
103. Wilbur EL, Stevens JB. Morbid anatomic changes following artificial fever, with report of autopsies. South Med J 1937; 30: 286-90.
104. Wilson SJ, Doan CA. The pathogenesis of hemorrhage in artificially induced fever. Ann Intern Med 1940; 13: 1214-29.
105. Kim YD, Lake CR, Lees DE. Hemodynamic and plasma catecholamine responses to hyperthermia cancer therapy in humans. Am J Physiol 1979; 237: H570-74.
106. Cronau LH, Bourke DL, Bull JM. General anesthesia for whole-body hyperthermia. Cancer Res 1984; 44 (Suppl.): 4873s-77s.
107. Vertrees RA, Tao W, Deyo DJ, Brunston Jr R, Zwischenberger JB. Veno-venous perfusion-induced hyperthermia: effect on hemodynamics. FASEB J 1996; 10: A1016.
108. Zwierzina WD, Herold M, Gunther R, Kunz F. Blood coagulation in hyperthermia. Zietschrift für Rheumatologie 1980; 39: 368-78.
109. Di Blasi S, Pintacuda S, Ferotti N et al. Influence of high environmental temperature on various parameters of blood coagulation in healthy subjects and in thrombosis risk patients. Minerva Medica 1987; 78: 1655-63.
110. Strother SV, Bull JM, Branham SA. Activation of coagulation during therapeutic whole body hyperthermia. Thrombosis Res 1986; 43: 353-60.
111. Groza P, Artino-Radulescu M, Nicolescu E, Munteanu A. Blood coagulation and fibrinolysis in hyperthermic rats. Physiologie 1987; 24: 213-20.
112. Eisler K, Landauer B, Hipp R et al. Experiences with therapeutic whole-body hyperthermia. Anaesthesist 1985; 34: 299-303.
113. Groom RC, Hill AG. Hyperthermic cancer treatment: systemic hyperthermia and isolated limb perfusion. Proc Am Acad Cardiovasc Perfusion 1987; 8: 105-11.
114. Douglas MA, Parks LC, Bebin J. Sudden myelopathy secondary to therapeutic total-body hyperthermia after spinal-cord irradiation. Medical Intell 1981; 304: 583-85.
115. Herman TS, Zukoski CS, Anderson RM. Review of the current status of whole-body hyperthermia administered by water circulation techniques. Natl Cancer Inst Monogr 1982; 61: 365-69.